New investment and strategic resources will fuel the development of enhanced ID Plans solution ecosystem capabilities

TAMPA, Fla., Oct. 29, 2026 — ID Plans, a leading provider of property intelligence and technology solutions for the commercial real estate industry, today announced a strategic investment from Polaris Growth Fund (PGF), a Boston-based private equity firm that partners with founder-led software and technology-enabled services companies. The partnership will provide ID Plans with additional capital, strategic resources, and operational expertise to support its expansion across the commercial real estate market and accelerate innovation and development of new capabilities. 

“This is an exciting next chapter for ID Plans,” said Jeff Landry, ID Plans founder and CEO. “We have built an incredible company because of our people, our customers, and our relentless focus on solving real challenges in commercial real estate. In PGF, we found a partner that believes in what we have built and shares our vision for what ID Plans can become. Their experience, resources, and growth mindset will help us move faster, invest in our capabilities, and create even greater value for our customers.”

ID Plans has developed a leading property intelligence and management solution ecosystem since its founding in 1999. The investment from PGF will empower ID Plans to scale while preserving its focus on providing customers with a solution that reflects their lived experiences and comprehensive support to overcome emerging industry challenges. ID Plans will continue to operate under its existing name and leadership team. 

“ID Plans has built a differentiated business with a talented team, strong customer relationships and significant opportunity ahead,” said Dan Lombard, PGF managing partner. “We are excited to partner with Jeff and the ID Plans executive leadership team to build on the company’s strong foundation. We see meaningful opportunities to invest in the platform, expand the company’s reach, and support ID Plans as it enters its next phase of growth.”

Software Equity Group served as the financial advisor to ID Plans.

About ID Plans

ID Plans is a property intelligence suite for commercial real estate designed to take a space from vacant to occupied to renewed. The company was founded in 1999 and uses a nationwide field staff, 3D cameras, and aerial drones to create full space profiles for retail, office, industrial, manufacturing, and government buildings. ID Cloud is a centralized commercial property management operating system that powers the ID Plans product ecosystem, which is a fully integrated set of solutions for end-to-end tenant management, exterior asset management, virtual property tours, proactive maintenance intelligence, and more. Learn more at www.idplans.com.

About Polaris Growth Fund

Polaris Growth Fund is a software-focused, specialized affiliate fund of Polaris Partners, a Boston-based private investment firm with two decades of technology and healthcare investing experience. Polaris has offices in Boston, San Francisco, and New York. For more information, visit www.polarisgrowthfund.com.

Media Contact
ID Plans
Sarah Darling
Head of Marketing
[email protected]

SOURCE ID Plans

Angel Investor Forum leads round as Urologic Design prepares for first-in-human study

BRANFORD, CT, Oct. 29, 2026 — Urologic Design, a start-up commercializing innovations in urology care, today announced the closing of a $1.2M pre-seed fundraise. The equity funding will help the company develop its first product, a patented medical device for managing urinary incontinence. The investment will also support continued R&D activities, regulatory work, and preparation for the company’s first-in-human clinical study.

The oversubscribed round was led by Angel Investor Forum, Connecticut’s primary angel group, and joined by HBS Alumni Angels of Boston, Haven Founders Fund, Connecticut Innovations, and Yale Angels, in addition to several individual investors.

“AIF invests in companies addressing meaningful unmet needs with differentiated solutions,” said Matthew Stannard, Life Sciences Lead at Angel Investor Forum. “Urologic Design impressed us with its approach to bridging the gap between absorbent products and surgery for managing urinary incontinence. We are excited to support the company as it advances toward first-in-human testing, an important step on the path to commercialization.”

The funds will enable Urologic Design to further refine and test its first product—a urethral occlusion device for men. The company has already developed a working prototype, secured IP protection, and conducted extensive bench testing. Preparations are beginning for an initial clinical study involving a small cohort of men with stress urinary incontinence.

“For the 25 million people living with urinary incontinence in the United States, the available options are uncomfortable, cumbersome, and difficult to incorporate into everyday life,” says Dr. David Hesse, Co-Founder and Chief Scientific Officer of Urologic Design. “We founded Urologic Design to develop a simple, temporary solution that gives people greater dignity, control, and confidence in managing leakage—all while fitting naturally into their daily lives.”

About Urologic Design
Urologic Design is a start-up that commercializes innovations in urology care. The company was founded in 2022 by Dr. David Hesse, who is the Chief Scientific Officer and an Associate Professor of Urology at the Yale School of Medicine. Urologic Design is headquartered in Branford, CT. For more information, visit www.urologicdesign.com.

Urologic Design Media Contact
[email protected]

SOURCE Urologic Design

Co-led by Lightbank VC and Arteria Capital, the pre-seed round will accelerate the expansion of Wrapped Health’s AI-native infrastructure across independent practices, health systems, and digital health platforms

WASHINGTON, Oct. 29, 2026 — Wrapped Health, the digital infrastructure startup connecting clinical care with consumer health, today announced $2.1 million in pre-seed funding co-led by Lightbank and Arteria Capital, the healthcare AI fund founded by Russell Glass. Wrapped Health will leverage this funding to expand product and engineering development, integrate with additional electronic health record (EHR) systems, and cultivate partnerships with provider organizations, health systems, and digital health platforms.

Healthcare has digitized prescriptions, labs, and imaging, but the everyday health products clinicians recommend remain largely disconnected from traditional care channels. Ninety percent of consumers say a physician has recommended an over-the-counter (OTC) treatment, yet these recommendations are communicated verbally, in a handwritten note, or buried in an after-visit summary, leaving patients to find the right products on their own.

This presents a significant opportunity. According to the Centers for Medicare & Medicaid Services (CMS), Americans spend nearly $124 billion annually on over-the-counter medicines and other non-durable medical products. Consumer health spending continues to grow, yet traditional healthcare remains largely disconnected from the purchases it helps drive. Wrapped seeks to give healthcare organizations a direct connection to the consumer health market they already help drive, opening new opportunities for patient engagement and personalized care.

Wrapped Health is building AI-native infrastructure to bring agentic commerce to healthcare, bridging the gap between clinical care and retail commerce and services. Integrated into the EHR, Wrapped understands clinical context, anticipates patient needs, and personalizes health recommendations, whether during a doctor’s visit or at key moments throughout care, from pregnancy and postpartum to chronic condition management and post-surgical recovery. By connecting patients directly to trusted retailers and helping them use available FSA/HSA benefits, Wrapped makes it easier to turn clinical guidance into action and brings the convenience of modern commerce to healthcare.

“Patients can buy almost anything with one click, except the products their doctor tells them they need,” said Max Russell-Harris, co-founder and CEO of Wrapped Health. “Healthcare has built digital systems for prescriptions, labs, and imaging, but there’s still a huge gap when it comes to everyday health products. We’re building that missing connection. It shouldn’t matter whether you’re seeing your local doctor, visiting a major health system, or getting care online. If your provider recommends something, getting it should be the easy part.”

“Every prescription, lab and scan gets sent, tracked and filled. The doctor’s ‘go buy this’ walks out the door on a sticky note,” said Eric Ong, Partner at Lightbank. “Wrapped Health turns that recommendation into a one-tap order and delivers it the same day. We are excited to back Max and the team, and believe that Wrapped Health can be core infrastructure for clinician workflows.”

“One thing I’ve learned building consumer health companies is that convenience is what drives people to take action,” said Russell Glass, founder and general partner of Arteria Capital and former CEO of Headspace. “Yet there’s a huge disconnect between the guidance patients receive from healthcare providers and the products and services they need to manage their health. Wrapped is building the AI-native infrastructure to close that gap, creating an enormous opportunity to connect traditional healthcare with the growing consumer health economy.”

Wrapped is available through the athenahealth Marketplace to more than 180,000 clinicians on the athenaOne network.

About Wrapped Health

Wrapped Health is a healthcare technology company making it easier for patients to get the health products and services their providers recommend. Through integrations with electronic health records and digital health platforms, Wrapped connects clinical guidance with convenient purchasing, available health benefits, and fulfillment through major retailers. By bridging healthcare and retail, Wrapped helps providers extend their care beyond the exam room while giving patients the convenience they expect in other parts of their lives. Founded by Max Russell-Harris, Wrapped Health is based in Washington, DC. Learn more at getwrappedhealth.com

Media Contact:
[email protected]

SOURCE Wrapped Health

The joint venture will launch with a seed portfolio targeting up to 1.2 GW of capacity in PJM; SVP’s commitment will also support the expansion of NewEdge’s platform.

GREENWICH, Conn. and NEW YORK, Oct. 29, 2026 — Strategic Value Partners, L.P. (together with its affiliates, “SVP”), a global alternative investment firm, and NewEdge Power (“NewEdge”), a utility-scale and distributed power development platform, today announced a partnership under which funds managed by SVP (the “SVP Funds”) will make an initial capital commitment to establish a joint venture focused on utility-scale power and supporting the expansion of NewEdge’s platform. The partnership builds on NewEdge’s existing backing from SJF Ventures, which led its Series A financing in 2025, and from its initial investment partners, Segue Sustainable Infrastructure and North Sky Capital. Terms of the transaction were not disclosed.

NewEdge’s pipeline includes utility-scale battery storage and solar projects, as well as distributed power projects, across several U.S. power markets. The joint venture will launch with a seed portfolio targeting up to 1.2 GW of capacity in PJM, the grid operator serving 13 states and Washington, D.C. SVP’s commitment will enable NewEdge to advance this portfolio and pursue additional opportunities in PJM and other U.S. markets.

The partnership comes as PJM and other U.S. power markets face growing demand for electricity. Manufacturing, electrification and data center growth are increasing the need for new capacity that can come online quickly. Battery storage is one resource that can help meet that need on a tight timeline and cost effectively.

“For decades, power availability was taken for granted as demand stayed flat. Today, with unprecedented demand growth driven by data centers and the reshoring of manufacturing, we’re seeing a need for new resources to serve the market. Battery storage has emerged as a critical part of the solution that can be delivered quickly to meet this need,” said Joe Nano, Chief Executive Officer and Co-Founder of NewEdge. “SVP brings the scale, expertise and conviction to build on our platform’s successful track record and expand our capabilities to serve the U.S. power market during this window of opportunity.”

“Power markets are being reshaped by rising electricity demand and the need to bring new capacity online at pace. However, power demand is only part of the story. In markets like PJM, securing well-located sites and a viable path to the grid is a significant part of the growing opportunity we are seeing,” said Mike Ungari, Global Head of Real Estate at SVP. “This partnership combines NewEdge’s expertise to identify and advance those sites with SVP’s capabilities investing across power and infrastructure.”

NewEdge will lead development under the joint venture, with SVP funding select projects as they progress. SVP’s platform investment in NewEdge will also be funded over the investment period to support and expand the company’s development team and capabilities.

“We’ve built NewEdge around securing high-quality sites and interconnection positions in the markets where new capacity is needed most,” said Steve Barna, Chief Development Officer and Co-Founder of NewEdge. “With SVP’s capital, we believe we can move our seed portfolio and pipeline through development at the pace this market requires.”

As part of the transaction, Andrew Shore, Managing Director, North American Investment Team at SVP, will join NewEdge’s Board of Directors as an observer, alongside Joe Nano and Steve Barna of NewEdge, Dave Kirkpatrick and Alan Kelley of SJF Ventures, and independent director Brent Beerley. The board brings deep power-sector experience, including SJF Ventures’ clean energy investments in Terabase Energy, Nextpower (NASDAQ: NXT, formerly Nextracker), Community Energy (sold to AES) and groSolar (sold to EDF), and Mr. Beerley’s two renewable company exits, to Iberdrola Renewables and AES.

Ackman-Ziff Real Estate Group LLC served as financial advisor to NewEdge on the transaction. Verdonck Partners LLC served as buy-side advisor to SVP. Amis, Patel & Brewer, LLP served as transaction counsel to NewEdge. Gibson, Dunn & Crutcher LLP served as transaction counsel to SVP.

About NewEdge Power
NewEdge Power is a utility-scale and distributed power development platform active across several key U.S. power markets. The company develops utility-scale battery storage, utility-scale solar and distributed power projects. NewEdge’s executive team has successfully created leading development platforms and independent power companies across both renewable and conventional power. Collectively, the team has worked on and delivered more than 48 GW of power projects across solar, battery storage, wind, geothermal, hydroelectric and conventional power. Follow NewEdge on LinkedIn or visit newedgepower.com.

About SVP
SVP is a global alternative investment firm that invests across the full range of opportunistic strategies – from performing and event driven debt to hybrid solutions, hard assets (infrastructure, real estate, power, airplanes) and special situations private equity. It has extensive resources to improve or transform companies, as well as hard assets with a team of in-house operating partners, and operating platforms in power, retail real estate and aviation. Today, SVP has approximately $22 billion in assets under management and, since inception in 2001, has invested more than $60 billion of capital. The firm, established by Victor Khosla, has over 200 employees, including over 100 investment professionals, across its main offices in Greenwich (CT), New York and London, and presences in Tokyo and Dubai. Learn more at www.svpglobal.com.

Media Contacts

NewEdge Power:
[email protected] 

Strategic Value Partners:
[email protected]

SOURCE Strategic Value Partners

Former Equity Residential, GID Investment Advisers and Prelude Capital Alumni Team Up to Address Market Dislocation

NEW YORK, Oct. 29, 2026 — Real estate investment veterans Vincent DiSalvo and Michael Gallagher today announced the formation of Contrada, a U.S. housing investment manager focused on special situations. The firm officially launches alongside a strategic anchor investment from a multigenerational New York development firm.

The launch comes as the U.S. housing market enters a period of dislocation where realizable price is increasingly disconnected from long-term value. This environment is driven by financing pressure as low-rate loans mature into a higher-rate environment, alongside mounting operational hurdles.

“Across the country, capital structures are broken,” said Vincent DiSalvo, Founder and Chief Investment Officer of Contrada. “Operators are seeing that rent growth is proving to be a less effective hedge against inflation than in previous cycles, while operating expenses continue to rise disproportionately. However, at the right entry basis, exceptional value can be unlocked and a meaningful complexity premium earned.”

Despite these pressures, long-term demand remains intact, as the U.S. faces an estimated shortage of nearly three million homes, with cost and regulatory barriers continuing to constrain future supply. Targeting this disconnect through its flagship U.S. Housing Dislocation Fund, Contrada is actively acquiring dislocated properties and performing and non-performing loans, and recapitalizing select projects in durable locations. The strategy pairs institutional capital with a team that has built, financed and restructured housing assets across cycles.

“I grew up in New York City construction before moving into institutional investment,” added DiSalvo. “This background allows us to apply a builder’s discipline to accurately underwrite assets burdened by temporary friction.”

Contrada’s leadership team has collectively invested in more than 17,800 apartment homes and 900 loans nationwide, representing over $2.5 billion in asset value. DiSalvo previously served as Chief Investment Officer at Kingbird Investment Management, the real estate investment arm of a Puerto Rico-based family office, following institutional investment roles at Equity Residential and GID Investment Advisers. Michael Gallagher, Co-Founder and Managing Partner at Contrada, most recently led the effort to build and scale the private equity real estate investment platform at Prelude Capital, a hedge fund adviser with over $5 billion of total allocations outstanding. He started his career as a real estate attorney at Proskauer Rose LLP, where he advised New York City sponsors and lenders on complex transactions and workouts.

“The current wave of maturing debt is creating a narrow opening to acquire fundamentally sound assets with broken balance sheets,” said Gallagher. “Contrada was built for the rare deployment window ahead.”

For more information, visit www.contrada-re.com or email [email protected].

SOURCE Contrada Real Estate

Silver Point Capital and Victory Park Capital join a four-year facility through USD.AI‘s GPU Loan Exchange (GLX) to finance GPU capacity in Finland.

NEW YORK, Oct. 29, 2026 — USD.AI, the platform financing the Compute Middle Market, today announced that it has led and closed a $106 million senior secured term loan facility for NexGen Cloud, a leader in scalable, sustainable AI Cloud solutions across Europe. This transaction marks another milestone for USD.AI as it continues to serve the Compute Middle Market—GPU operators and AI infrastructure businesses below the hyperscaler tier—and is NexGen Cloud’s second financing with USD.AI. It follows the $34 million facility announced in June 2026 for NexGen Cloud’s NVIDIA B200 deployment in Sweden. Together the two facilities bring USD.AI’s financing for NexGen Cloud to $140 million across two countries.

Silver Point Capital and Victory Park Capital participated as lenders alongside USD.AI. The four-year facility finances 216 NVIDIA HGX B300 servers, 1,728 GPUs in total, at a Tier III data center in Finland. The escrow funding date is aligned with shipment of the servers, which is expected in Q4 2026. The capacity is fully contracted under a take-or-pay agreement with a leading AI inference platform, and the loan amortizes over the same term.

USD.AI arranged the facility and served as administrative agent through its newly launched GPU Loan Exchange (GLX) which connects standardized, serviced GPU-backed loans with institutional capital.

GLX launched on October 1, 2026 with a $98 million season-and-sell transaction for Duos Edge AI. USD.AI has originated more than $500 million of GPU financing this year, and with the NexGen Cloud facility, more than $200 million of that has now gone through GLX.

“NexGen Cloud came back to us for a facility three times the size of the first, and this time we led it alongside two established credit investors,” said Conor Moore, Chief Operating Officer and Co-Founder of USD.AI. “That is what GLX is for: bringing institutional capital into the largely underserved Compute Middle Market, and putting it behind established, fast-growing neoclouds like NexGen Cloud.”

“The compute needs of our customers are growing significantly and at a rapid pace. Having access to reliable financing solutions to facilitate that demand is essential to our success,” said Chris Starkey, Chief Executive Officer of NexGen Cloud. “Sourcing capital through USD.AI’s GLX gives us the speed and certainty to convert customer demand into deployed AI capacity across Europe. The USD.AI team’s approach to many of the finance challenges we sometimes face is what separates them from others. We look forward to continuing our business growth together.”

About USD.AI

USD.AI operates the GPU Loan Exchange (GLX), the marketplace connecting institutional capital with AI infrastructure operators across the Compute Middle Market. It originates, structures and agents senior secured loans backed by GPUs and the contracted cashflows they generate, and places them with institutional credit investors through GLX. Borrowers get speed and certainty of execution. Lenders get secured exposure to income-producing compute, underwritten with institutional rigor. For more information, visit https://usd.ai.

About NexGen Cloud

NexGen Cloud is the foremost provider of sovereign-by-design, full-stack AI cloud environments for the global market. Purpose-built AI infrastructure for the demands of modern AI workloads, NexGen Cloud’s solutions include Hyperstack Secure Private Cloud for single-tenant enterprise deployments, and Hyperstack On-Demand, a full stack AI cloud platform offering GPUaaS. As an NVIDIA Cloud Partner, the company hosts its managed infrastructure in data centres across Europe and North America. For more information, visit www.nexgencloud.com.

About Silver Point Capital

Silver Point Capital is a leading global credit investing firm founded in 2002. With a dedicated team of over 400 employees, Silver Point Capital oversees over $48 billion in investable assets across a comprehensive credit platform that includes public and private investment strategies. Silver Point Capital’s Direct Lending business works in close partnership with both private equity-backed and sponsor-less borrowers, with a flexible mandate designed to allow clients to execute on M&A, refinancings and growth capital, among a range of transaction types. Silver Point Capital’s Direct Lending business manages over $18 billion in investable assets. For more information, please visit www.silverpointcapital.com.

About Victory Park Capital Advisors, LLC

Victory Park Capital Advisors, LLC (“VPC” or the “Firm”) is a global alternative asset manager that specializes in private credit and asset-backed finance. The Firm also offers structured financing and capital markets solutions through its affiliate platform, Triumph Capital Markets. Founded in 2007 and headquartered in Chicago, VPC became a majority-owned affiliate of Janus Henderson Group in 2024, gaining access to the firm’s 2,000+ employees across offices in 27 cities worldwide. Victory Park Capital is a Registered Investment Advisor with the SEC. Registration with the SEC does not imply a certain level of skill or training. Triumph Capital Markets (TCM) is a U.S. registered broker-dealer and operates solely within the United States. It is not registered to conduct securities business in any other jurisdiction. For more information, please visit www.victoryparkcapital.com.

SOURCE USD.AI

Founded by Replika creator Eugenia Kuyda, Wabi is redefining personal AI as something people can use together, combining an AI agent and personalized mini-apps to help people pursue interests, navigate life’s challenges, and do more of what they love

SAN FRANCISCO, Oct. 29, 2026 — Following strong interest in its recent public launch, Wabi, a new kind of personal AI assistant built for life together, today announced $55 million funding led by IVP, at a $1.25 billion valuation. Other participants included Andreessen (a16z), Forerunner, Amazon Alexa Fund and top angels and founders including Tobi Lütke, Marc Benioff, Marissa Mayer, Dick Costolo, and Alex Pall.

Founded by Eugenia Kuyda, who previously founded AI companion platform Replika, Wabi is reimagining what a personal AI agent can be. While most AI assistants today are built for one person typing into one chat, Wabi is betting the next era of personal AI happens between people; from the newlyweds excited about their next adventure, the book club planning its next themed night, the running group coordinating their next weekend route, the family sharing the mental load of running a household, to the friends who want to see more live music. Wabi combines an AI agent, personalized mini-apps, and shared spaces so people can put AI to work across their interests, relationships, and everyday lives.

“AI shouldn’t just save people time. It should help them spend it better, doing more of what they love, with the people they love,” said Eugenia Kuyda, founder and CEO of Wabi.  “We believe Wabi has the power to become an operating system for life, a place where your people, your tools, and your AI come together to help you do more of what matters. As AI becomes more capable, it should help us not just get things done, but pursue our goals, discover new experiences, and show up for one another. We’re building Wabi around that vision.”

Since launch, users have found creative ways to use Wabi together. Friends have used it to discover new bands based on their shared musical tastes, run 30-day fitness challenges, and find thoughtful ways to check in on each other during hard times. Couples have used it to proactively plan date nights and keep the spark alive. Individuals have used it to build routines around personal goals and get step-by-step guidance through a breakup.

Personalized mini-apps make these interactions more than one-off chats. Couples can keep a running list of new restaurants to try and check them off together, families can share a weekly meal plan that turns into a grocery list, and friends can build trivia games for milestone birthday celebrations or trackers for their book club. These tools can be revisited and adapted over time, giving people a way to turn an idea into something they can keep doing together. Wabi also helps with everyday responsibilities, from coordinating family schedules and helping children with homework to booking appointments and planning trips.

“Eugenia has a unique sense for where AI is headed and a track record of great taste in building it,” said Alex Lim, General Partner at IVP. “She has a clear vision for how people will interact with AI, one that goes far beyond the text box or command line. Wabi is the expression of that vision, and we’re thrilled to support her.”

“Eugenia Kuyda is one of the most incredible consumer thinkers I know. She was early and right about AI companions, and she thinks deeply about what people actually want. Eugenia knows personal agents need more than just a chat interface, so she’s building Wabi as a shared place to plan, play and get things done together. It’s a thoughtful bet in a space that’s moving fast, and we’re proud to have been in her corner since the pre-seed,” said Anish Acharya, general partner at a16z. 

The new funding will support Wabi’s continued product development and expansion.

For more information about Wabi and how to access, please visit wabi.ai or directly download on iOS, Android and Mac, with Windows coming soon.

About Wabi

Wabi is an AI assistant designed to help people do more of what they love with the people they love. Combining multiplayer collaboration, personalized mini-app creation, and proactive AI assistance, Wabi helps people coordinate plans, manage everyday life, and create shared experiences. Learn more at https://wabi.ai/ or on socials at Twitter: https://x.com/wabi, Instagram: https://www.instagram.com/wabimaxxing, and Linkedin: https://www.linkedin.com/company/joinwabi/.

Media Contact:
Rachel Rogers
3107704917
[email protected]

SOURCE Wabi

• Crux Labs emerges from stealth and raises over $6M in oversubscribed round
• Platform uses frontier science to align AI agents with expert judgment
• Strong traction with Fortune 500s and high-growth companies across healthcare, cybersecurity, financial services, and other high-stakes industries

NEW YORK, Oct. 29, 2026 — Crux Labs, the first platform to turn enterprise judgment into continuous agent improvement, today emerged from stealth and announced a $6+ million oversubscribed funding round. The round was co-led by Benchstrength and Misneach, with participation from Analog Ventures and Pareto Holdings. Crux will use the funding to expand its research and engineering efforts while accelerating deployments with enterprise customers.

Today, companies from start-ups to the Fortune 500 are deploying AI agents at scale without a reliable way to measure and improve their performance. Many teams sample just 1% of agent traces for manual review, missing many of the failures that live at the tails of a broad distribution. Existing observability platforms make agent traces easier for humans to inspect but fail to monitor and improve agent performance across millions of user interactions. The result is customer frustration, engineering teams mired in support tickets, and ultimately revenue churn.

The Crux platform addresses this challenge by bringing dedicated agent evaluation and improvement capabilities to every enterprise. Crux agents capture expert judgment inside each company’s native workflows and calibrate custom evaluations to that judgment. These evaluations power real-time monitoring across 100% of traffic and drive continuous agent improvements shipped directly to production.

“Aligning AI agents to human judgment is one of the biggest challenges of our time,” said Julie Kheyfets, Cofounder and CEO of Crux. “Agents are incredible at attaining goals, but they lack access to the years of heuristics that we as humans have collected in our heads. Crux helps every enterprise to distill this judgment and to use it to rapidly improve their agents.”

The company has seen strong traction from high-growth startups and Fortune 500 enterprises across healthcare, cybersecurity, financial services, and other complex industries. Teams rely on Crux to manage their agent evaluation and improvement efforts, freeing up engineering and product bandwidth to ship new features.

“Engineering teams know how to build AI agents, and subject matter experts know what success looks like, but enterprises lack the bridge between them,” said Krishna Kulkarni, Cofounder and CTO of Crux. “Crux operationalizes domain expertise into continuous agent improvement so engineers can build truly business-aligned agents.”

“The companies that win with AI will have agents that reflect the judgment of their best people,” said John Monagle, General Partner, Benchstrength. “Crux makes this possible across every agent interaction, and Julie and Krishna are uniquely suited to build it. We’re proud to back a team that is transforming how enterprises put agents to work.”

Kheyfets and Kulkarni met at Princeton. Kheyfets brings a decade of experience deploying AI in complex industries, including leading North America for Tractable AI and leading Block Renovation as CEO. Kulkarni previously led brand engineering at Meta, developed AI products at Checkr, and scaled Healthify from 0 to 20M patients. They are rapidly scaling a team of researchers and engineers with deep expertise in evaluating and improving agents.

ABOUT CRUX LABS

Crux Labs is the first end-to-end platform that helps companies align AI agents with human judgment. The platform captures domain expertise, creates and calibrates custom evaluations, monitors 100% of production traffic, and turns evaluation results into continuous agent improvement directly in production. Crux gives enterprises the capabilities of a dedicated evaluation science team, accelerating agent performance and impact while freeing up product and engineering bandwidth. Learn more at crux-labs.ai.

SOURCE Crux Labs

Financing follows peer-reviewed NeuroPulse pilot study results and supports a pivotal trial of Rhyvive™, an investigational adjunctive therapy designed to extend AF treatment beyond the hospital and into the home.

LOS ANGELES, Oct. 29, 2026 — StimCardio, a clinical-stage medical device company developing non-invasive wearable therapeutics for atrial fibrillation (AF), today announced the closing of its oversubscribed $30 million Series A financing led by John Slump’s family office, Metis Medtech, with participation from Catalyst Health Ventures, multiple corporate strategic investors, and other new and existing investors. The financing is expected to fund StimCardio through its planned NeuroPulse 2 pivotal study as well as the preparation for a De Novo submission to the U.S. Food and Drug Administration (FDA).

“Our vision is to establish non-invasive neuromodulation as a new therapeutic category in cardiac electrophysiology,” said Amir Soltanianzadeh, CEO of StimCardio Medical. “This financing brings together investors with deep expertise in cardiac device innovation and provides the resources to deliver a first-of-its-kind, multicenter pivotal study. With encouraging clinical evidence to date and a growing research program, we see an opportunity to extend treatment beyond the procedure room and improve outcomes for the millions of people living with AF.”

“StimCardio is pioneering innovative technology positioned to disrupt the cardiac electrophysiology arena,” said John Slump, CEO and founder of Metis MedTech and a StimCardio board member. “Despite decades of advances in catheter ablation procedures, AF recurrence remains a significant unmet clinical challenge. StimCardio has an entirely different approach with a non-invasive wearable that we believe will redefine the treatment paradigm. Our decision to invest reflects our strong conviction in this impressive team, disruptive technology, and growing market.”

Advancing a New Approach to AF Treatment

According to a 2025 analysis of Global Burden of Disease data published in the Journal of the American College of Cardiology, approximately 59 million people worldwide are living with atrial fibrillation. Catheter ablation is an established treatment for AF and is recommended as a first-line rhythm control therapy for selected patients under the 2023 ACC/AHA/ACCP/HRS clinical guidelines. Despite significant advances in catheter ablation technology, including pulsed field ablation (PFA), recurrent AF remains a persistent clinical challenge. Today, approximately 30% to 40% of patients experience recurrent AF following an initial ablation procedure.

StimCardio’s lead investigational product, Rhyvive, is a wrist-worn therapeutic wearable designed to deliver personalized, non-invasive median nerve stimulation (MNS) through a closed-loop system that integrates physiological sensing and neuromodulation. Developed as an adjunct to catheter ablation, Rhyvive is designed to extend treatment beyond the procedure and into the patient’s home by modulating autonomic nervous system pathways with the goal of reducing recurrent atrial arrhythmias such as AF.

“Catalyst Health Ventures invests early in paradigm-shifting technologies with the potential to transform patient care,” said Joshua Phillips, managing partner of Catalyst Health Ventures and a StimCardio board member. “StimCardio’s differentiated therapeutic approach targets a significant unmet clinical need affecting a large patient population. Supported by encouraging early clinical evidence, the technology has the potential to reduce AF recurrence following catheter ablation.”

Building on Clinical Evidence

The financing follows the presentation of StimCardio’s NeuroPulse 1 pilot study as a late-breaking clinical trial at HRX Live 2026 and its peer-reviewed publication in Heart Rhythm. The randomized, double-blind, sham-controlled study demonstrated a statistically significant reduction in recurrent atrial arrhythmia events post-ablation with active MNS stimulation compared with the sham treatment group.

NeuroPulse 2 will be a major, multicenter pivotal trial designed to evaluate whether adding wearable neuromodulation to catheter ablation improves clinical outcomes compared with ablation alone.

About StimCardio Medical

StimCardio Medical is a clinical-stage medical device company pioneering non-invasive, wearable neuromodulation therapeutics for cardiac rhythm disorders. Its primary investigational technology, Rhyvive, uses median nerve stimulation to target autonomic pathways involved in atrial fibrillation (AF), offering a differentiated approach designed to complement existing cardiac treatments. The company’s initial clinical focus is improving outcomes following catheter ablation, with a longer-term vision to expand wearable neuromodulation into additional AF and cardiovascular applications. To explore StimCardio’s clinical research and publications, visit stimcardio.com, and follow the company on LinkedIn for updates.

About Metis MedTech

Metis MedTech is an investment and strategic advisory platform that supports innovative medical device companies through financing, commercialization, and long-term value creation. Led by CEO & Founder, John Slump, the company is built on his track record across four major medical device exits, including two in the cardiac electrophysiology market, Farapulse and Atraverse Medical, representing more than $1.25 billion in aggregate M&A transaction value. Metis MedTech works with technical founders and physician innovators advancing differentiated technologies in cardiovascular, neurovascular, and other high-impact medical device markets. Founders seeking aligned capital and operator-level partnership may visit metismedtech.com.

CAUTION: Investigational device. Limited by United States law to investigational use.

Media Contact
Holly Windler
619-929-1275
[email protected]
[email protected]

SOURCE StimCardio Medical Inc.